EIP Pharma, Inc. — Form D
EIP Pharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-15. The offering totals $10.0M, of which $5.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-01-15
- Form: D
- Accession: 0001736525-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.1M
- Remaining: $4.9M
- Investors: 28
- Date of first sale: 2020-12-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-386574
Issuer
- Name: EIP Pharma, Inc.
- CIK: 0001736525
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Phone: 617-744-4400
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Tatjana May | Director | Boston, MA |
| Noel Donnelly | Executive Officer | Boston, MA |
| JEFF POULTON | Director | Boston, MA |
| WILLIAM TURNER | Executive Officer | Boston, MA |
| SYLVIE GREGOIRE | Director | Boston, MA |
| SYLVIE GREGOIRE | Executive Officer | Boston, MA |
| FRANK ZAVRL | Director | BOSTON, MA |
| KELLY BLACKBURN | Executive Officer | BOSTON, MA |
| JOHN ALAM | Director | BOSTON, MA |
| JOHN ALAM | Executive Officer | BOSTON, MA |
| MARWAN SABBAGH | Director | Boston, MA |
Other filings by this issuer (5)
More